As part of its strategic planning, the University Medical Center Göttingen (UMG) in the heart of Germany is pursuing the consistent further development of its profile-forming priority research areas Molecular Cell Biology, Neurosciences, Cardiovascular Medicine and Oncology. With its German Centers for Health Research partner (DZHK, DZNE and DZKJ), the excellence cluster “Multiscale Bioimaging”, collaborative research centers, and other collaborative research grants, the UMG offers a dynamic and collaborative research environment. As partner at the Göttingen Campus, we foster close ties with the university’s natural and life sciences institutions, as well as non-university research institutions, to advance groundbreaking research and discoveries.

The decisions on the largest funding initiative in the history of the German state of Lower Saxony have been made: ‘Potenziale strategisch entfalten’, the joint funding programme of the Lower Saxony Ministry of Science and Culture and the Volkswagen Foundation, will support the universities in Lower Saxony with a total of 265 million euros. The UMG will receive 18.5 million euros of the total funding. This funding enables us to successfully pursue the goals set out in our proposal ‘UMG 2032 – Excellence through Focus’ in the coming years.

Over the course of the project, we will focus on bringing together our four established priority research areas and unite them under the cross-organ and cross-disease concept of Metabolic Plasticity. In the coming years, we aim to strengthen collaborative research activities and promote outstanding scientists at all career levels. In addition to networking and promoting talent, we place particular emphasis on deepening the integration of technology transfer to ensure that new scientific knowledge is rapidly made available to society. Taken together, these five key topics mentioned above reflect our commitment to progress and excellence in science.

We are looking for established scientists in an early career phase (up to 6 years post-PhD) who are passionate about making a substantial contribution to the further development of the topic of Metabolic Plasticity. As an Early Career Researcher leading a Junior Research Group at the UMG, you will have the opportunity to establish a cutting-edge research program with significant impacts in this field. We are particularly interested in candidates who can develop an innovative research agenda in areas such as:

•Mitochondrial Homeostasis (ECR 1)
•Inter-Organ Communication (ECR 2)
•Metabolic Neuroimmune Adaptations (ECR 3)
•Transcription and Metabolic Plasticity (ECR 4)
•Metabolomics Mass Spectrometry platform, Advancing Techniques for Studying Metabolic Plasticity (ECR 5)

#J-18808-Ljbffr

Dgmet